BlackRock’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.5M | Sell |
|
|||||
|
2025
Q2 | $14.6M | Sell |
|
|||||
|
2025
Q1 | $16.4M | Sell |
|
|||||
|
2024
Q4 | $34.7M | Buy |
|
|||||
|
2024
Q3 | $57.6M | Sell |
|
|||||
|
2024
Q2 | $50.8M | Buy |
|
|||||
|
2024
Q1 | $43.5M | Buy |
|
|||||
|
2023
Q4 | $468K | Sell |
|
|||||
|
2023
Q3 | $382K | Sell |
|
|||||
|
2023
Q2 | $402K | Sell |
|
|||||
|
2023
Q1 | $395K | Sell |
|
|||||
|
2022
Q4 | $312K | Sell |
|
|||||
|
2022
Q3 | $569K | Sell |
|
|||||
|
2022
Q2 | $938K | Sell |
|
|||||
|
2022
Q1 | $4.81M | Sell |
|
|||||
|
2021
Q4 | $12.6M | Sell |
|
|||||
|
2021
Q3 | $19.3M | Buy |
|
|||||
|
2021
Q2 | $24.4M | Sell |
|
|||||
|
2021
Q1 | $33.4M | Buy |
|
|||||
|
2020
Q4 | $37.9M | Buy |
|
|||||
|
2020
Q3 | $26.9M | Buy |
|
|||||
|
2020
Q2 | $36.3M | Buy |
|
|||||
|
2020
Q1 | $6.91M | Buy |
|
|||||
|
2019
Q4 | $7.47M | Buy |
|
|||||
|
2019
Q3 | $883K | Buy |
|
|||||
|
2019
Q2 | $730K | Buy |
|
|||||
|
2019
Q1 | $833K | Sell |
|
|||||
|
2018
Q4 | $673K | Buy |
|
|||||
|
2018
Q3 | $902K | Buy |
|
|||||
|
2018
Q2 | $815K | Sell |
|
|||||
|
2018
Q1 | $11.3M | Sell |
|
|||||
|
2017
Q4 | $11.9M | Sell |
|
|||||
|
2017
Q3 | $19.5M | Buy |
|
|||||
|
2017
Q2 | $19M | Sell |
|
|||||
|
2017
Q1 | $26.3M | Buy |
|
|||||
|
2016
Q4 | $1.11M | Buy |
|
|||||
|
2016
Q3 | $892K | Buy |
|
|||||
|
2016
Q2 | $335K | Hold |
|
|||||
|
2016
Q1 | $446K | Buy |
|
|||||
|
2015
Q4 | $508K | Sell |
|
|||||
|
2015
Q3 | $668K | Buy |
|
|||||
|
2015
Q2 | $158K | Sell |
|
|||||
|
2015
Q1 | $198K | Hold |
|
|||||
|
2014
Q4 | $181K | Hold |
|
|||||
|
2014
Q3 | $161K | Sell |
|
|||||
|
2014
Q2 | $245K | Hold |
|
|||||
|
2014
Q1 | $331K | Buy |
|